Validation of dried blood spot sampling in therapeutic drug monitoring of cyclospori
Recruiting
- Conditions
- Transplantation of hematopoetic stem cells or kidney10003816
- Registration Number
- NL-OMON34000
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
older than 18 years
Exclusion Criteria
No informed consent
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The CLSI EP09-A guideline is adapted.<br /><br>EP9 assumes that the two methods being compared will yield essentially<br /><br>identical results. The Medically Allowable Error is defined 15%. This Medical<br /><br>Allowable Error will be used to determine:<br /><br><br /><br>1. the maximum allowable difference between specimens across methods,<br /><br>2. the maximum allowable difference between duplicate specimens for the same<br /><br>method,<br /><br>3. the distance between the scatter plot bounds and the regression line. </p><br>
- Secondary Outcome Measures
Name Time Method